Feature | June 13, 2013

Mindray to Acquire Zonare Medical Systems

June 12, 2013 – Mindray Medical International Limited announced a definitive agreement to acquire Zonare Medical Systems, Inc., an ultrasound technology leader in the high-end radiology segment for US$105 million. Mindray’s management expects the deal to strengthen its high-end ultrasound R&D and U.S. sales capabilities, furthering the company’s goal of becoming a leading provider of high-quality imaging products to markets worldwide.

Total 2012 revenues for Zonare were approximately US$64 million. Mindray expects the deal to be slightly dilutive to its full-year 2013 and 2014 earnings.

Founded in 1999, Zonare is based in Mountain View, Calif. Over the past decade, Zonare has become one of the leading ultrasound brands in high-end radiology segment globally. Its world-class R&D team, comprising several leading ultrasound experts, developed the company’s revolutionary ZONE-Sonography technology to deliver superior image quality. Moreover, Zonare has a direct sales team mainly covering developed markets including the US, Canada, Scandinavia and Germany.

“We are very excited about this transaction. We evaluated many different acquisition targets and determined that ZONARE’s proven business model, along with its technology and sales channel assets, fits very well with our selection criteria,” said Minghe Cheng, Mindray’s co-chief executive officer. “This transaction will create significant synergies by combining Zonare’s strong innovative R&D capability and direct sales and service network in the high-end ultrasound market with Mindray’s efficient engineering and production platforms. We expect customers to benefit from the combined company’s expanded portfolio and improved ability to develop more innovative and customized products.”

Mindray plans to maintain Zonare’s brand and existing operations under its current management team led by Timothy A. Marcotte, Zonare’s president and chief executive officer. “The deal will create a global ultrasound company that is better positioned to serve the healthcare market on a worldwide basis,” commented  Marcotte. “We expect our customers to continue to benefit from the high level of innovation, quality and services provided by the Zonare brand. Moreover, as a member of the growing Mindray organization, we look forward to developing even more exciting products and technologies in the future by leveraging our combined strengths.”

The transaction is expected to close in the third quarter of 2013 and is subject to regulatory and other customary closing conditions. The final acquisition price is subject to working capital and other adjustments, and will be funded with Mindray’s existing cash and planned borrowings from third parties.

For more information: ir.mindray.com

 

 

 

Related Content

AI Approach Outperformed Human Experts in Identifying Cervical Precancer
News | Digital Pathology | January 10, 2019
January 10, 2019 — A research team led by investigators from the National Institutes of Health and Global Good has de
Artificial intelligence, also called deep learning and machine learning, was the hottest topic at the 2018 Radiological Society of North America (RSNA)) meeting.

Artificial intelligence was the hottest topic at the 2018 Radiological Society of North America (RSNA)) meeting, which included a large area with its own presentation therater set asside for AI vendors.

Feature | Artificial Intelligence | January 10, 2019 | Dave Fornell, Editor
Hands down, the hottest topic in radiology the past two years has been the implementation of...
Triton College Launching Vascular Technology in Sonography Certificate Program
News | Ultrasound Imaging | January 09, 2019
Starting in spring 2019, Triton College’s Vascular Technology in Sonography Certificate Program will help working...
Pacific Northwest VA Network Selects Carestream as Enterprise PACS Supplier
News | PACS | January 08, 2019
Carestream has been awarded a multimillion-dollar healthcare information technology (IT) contract for Veterans Affairs...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Sponsored Content | Videos | Flat Panel Displays | December 25, 2018
EIZO, which means image in Japanese, is a visual technology company that develops and manufactures high-end display s
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Fujifilm SonoSite Showcases Point-of-care Ultrasound Portfolio At RSNA 2018
News | Ultrasound Imaging | December 20, 2018
Fujifilm SonoSite Inc. recently present its complete portfolio of point-of-care ultrasound (POCUS) systems at the 2018...
IMS Announces Integration of Cloud Image Viewing Platform With Google Cloud
News | Archive Cloud Storage | December 20, 2018
International Medical Solutions (IMS) recently announced it will provide Google Cloud account users with the ability to...